Cargando…
Human Granzyme B Based Targeted Cytolytic Fusion Proteins
Cancer immunotherapy aims to selectively target and kill tumor cells whilst limiting the damage to healthy tissues. Controlled delivery of plant, bacterial and human toxins or enzymes has been shown to promote the induction of apoptosis in cancerous cells. The 4th generation of targeted effectors ar...
Autores principales: | Hlongwane, Precious, Mungra, Neelakshi, Madheswaran, Suresh, Akinrinmade, Olusiji A., Chetty, Shivan, Barth, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027395/ https://www.ncbi.nlm.nih.gov/pubmed/29925790 http://dx.doi.org/10.3390/biomedicines6020072 |
Ejemplares similares
-
Human MAP Tau Based Targeted Cytolytic Fusion Proteins
por: Akinrinmade, Olusiji A., et al.
Publicado: (2017) -
Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells
por: Mungra, Neelakshi, et al.
Publicado: (2019) -
CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL
por: Jordaan, Sandra, et al.
Publicado: (2017) -
CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases
por: Akinrinmade, Olusiji A., et al.
Publicado: (2017) -
Designing the Sniper: Improving Targeted Human Cytolytic Fusion Proteins for Anti-Cancer Therapy via Molecular Simulation
por: Bochicchio, Anna, et al.
Publicado: (2017)